Cited by 271Liver Disease Diagnosis and TreatmentAlcohol Consumption and Health EffectsLiver Diseases and Immunity

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Non‐alcoholic steatohepatitis: another disease of affluence

Open access

James, *Oliver, Day, Christopher·1999·The Lancet

DOI 10.1016/s0140-6736(99)00163-4

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(99)00163-4

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
Self-citation
Nonalcoholic Steatohepatitis
Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors.
Wanless, I. R., & Lentz, J. S. (1990) · Hepatology · doi:10.1002/hep.1840120505 · Cited by 1,191
Cryptogenic Cirrhosis: Clinical Characterization and Risk Factors for Underlying Disease
Caldwell, S. H., Oelsner, D. H., Iezzoni, J. C., Hespenheide, E. E., Battle, E. H., & Driscoll, C. J. (1999) · Hepatology · doi:10.1002/hep.510290347 · Cited by 1,138
Nonalcoholic steatohepatitis: An expanded clinical entity
Bacon, B. R., Farahvash, M. J., Janney, C. G., & Neuschwander‐Tetri, B. A. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90235-6 · Cited by 1,137
The natural history of nonalcoholic fatty liver: A follow-up study
Teli, M. R., James, O., Burt, A. D., Bennett, M. K., & Day, C. P. (1995) · Hepatology · doi:10.1002/hep.1840220616 · Cited by 913
Self-citation
Obesity increases sensitivity to endotoxin liver injury: Implications for the pathogenesis of steatohepatitis
Yang, S. Q., Lin, H. Z., Lane, M. D., Clemens, M. G., & Diehl, A. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2557 · Cited by 818
Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis
Weltman, M., Farrell, G. C., Hall, P. D. L. Μ., Ingelman‐Sundberg, M., & Liddle, C. (1998) · Hepatology · doi:10.1002/hep.510270121 · Cited by 613
Hepatic steatosis: Innocent bystander or guilty party?
Day, C. P., & James, O. (1998) · Hepatology · doi:10.1002/hep.510270601 · Cited by 395
Self-citation
Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance
James, O., & Day, C. P. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80073-1 · Cited by 370
Self-citation

Show all 15 references

Research works printed but not linked: 1

Younossi, 1998, Patient characteristics predicting cirrhosis and death in non-alcoholic steatohepatitis, Hepatology, 28, 303A

Sorted by citations

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Triglyceride Metabolism in the Liver
Alves‐Bezerra, M., & Cohen, D. E. (2017) · Comprehensive physiology · doi:10.1002/cphy.c170012 · Cited by 1,324
Liver fibrosis in overweight patients
Ratziu, V., Giral, P., Charlotte, F., Bruckert, É., Thibault, V., Theodorou, I. D., Khalil, L., Turpin, G., Opolon, P., & Poynard, T. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70364-7 · Cited by 969
P EROXISOMAL β-O XIDATION AND P EROXISOME P ROLIFERATOR –A CTIVATED R ECEPTOR α: An Adaptive Metabolic System
Reddy, J. K., & Hashimoto, T. (2001) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.21.1.193 · Cited by 991
The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor α in the pathogenesis of non-alcoholic steatohepatitis
Wigg, A. J., Roberts-Thomson, I. C., Dymock, R. B., McCarthy, P. J., Grose, R. H., & Cummins, A. G. (2001) · Gut · doi:10.1136/gut.48.2.206 · Cited by 836
Non‐alcoholic fatty liver disease
Angulo, P., & Lindor, K. D. (2002) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.17.s1.10.x · Cited by 838
Dietary Habits and Their Relations to Insulin Resistance and Postprandial Lipemia in Nonalcoholic Steatohepatitis
Musso, G., Gambino, R., Michieli, F. D., Cassader, M., Rizzetto, M., Durazzo, M., Fagà, E., Silli, B., & Pagano, G. (2003) · Hepatology · doi:10.1053/jhep.2003.50132 · Cited by 772
Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association
Pagano, G., Pacini, G., Musso, G., Gambino, R., Mecca, F., Depetris, N., Cassader, M., David, E., Cavallo‐Perin, P., & Rizzetto, M. (2002) · Hepatology · doi:10.1053/jhep.2002.30690 · Cited by 754
Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis.
Pérez-Carreras, M., Del Hoyo, P., Martín, M. A., Rubio, J. C., Martín, A., Castellano, G., Colina, F., Arenas, J., & Solis-Herruzo, J. A. (2003) · Hepatology · doi:10.1002/hep.1840380426 · Cited by 734
A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis
Promrat, K., Lutchman, G., Uwaifo, G. I., Freedman, R. J., Soza, A., Heller, T., Doo, E., Ghany, M., Premkumar, A., Park, Y., et al. (2004) · Hepatology · doi:10.1002/hep.20012 · Cited by 726
Insulin resistance, inflammation, and non-alcoholic fatty liver disease
Tilg, H., & Moschen, A. R. (2008) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2008.08.005 · Cited by 484
Bifidobacterium longum with Fructo-Oligosaccharides in Patients with Non Alcoholic Steatohepatitis
Malaguarnera, M., Vacante, M., Antic, T., Giordano, M., Chisari, G., Acquaviva, R., Mastrojeni, S., Malaguarnera, G., Mistretta, A., Volti, G. L., et al. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1887-4 · Cited by 459
Phosphatidylcholine biosynthesis and lipoprotein metabolism
Cole, L., Vance, J. E., & Vance, D. E. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.09.009 · Cited by 463
Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease
Diraison, F., Moulin, P., & Beylot, M. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70061-7 · Cited by 435
Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients.
Ryysy, L., Häkkinen, A. M., Goto, T., Vehkavaara, S., Westerbacka, J., Halavaara, J., & Yki-Järvinen, H. (2000) · Diabetes · doi:10.2337/diabetes.49.5.749 · Cited by 431
Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease
Willner, I. R., Waters, B., Patil, S. R., Reuben, A., Morelli, J., & Riely, C. A. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.04667.x · Cited by 419
Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis
Contos, M. J., Cales, W., Sterling, R. K., Luketic, V. A., Shiffman, M. L., Mills, A. S., Fisher, R. A., Ham, J. M., & Sanyal, A. J. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.23011 · Cited by 400
Steatosis in chronic hepatitis C: Relative contributions of obesity, diabetes mellitus, and alcohol
Monto, A., Alonzo, J., Watson, J. J., Grünfeld, C., & Wright, T. L. (2002) · Hepatology · doi:10.1053/jhep.2002.35064 · Cited by 360
Randomized Placebo-Controlled Trial of Ursodeoxycholic Acid With Vitamin E in Nonalcoholic Steatohepatitis
Dufour, J., Oneta, C. M., Gonvers, J., Bihl, F. K., Cerny, A., Cereda, J., Zala, J., Helbling, B., Steuerwald, M., & Zimmermann, A. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.09.025 · Cited by 360
Hepatic Cytochrome P450 2E1 Activity in Nondiabetic Patients With Nonalcoholic Steatohepatitis
Chalasani, N., Gorski, J. C., Asghar, M. S., Asghar, A., FORESMAN, B. H., Hall, S. D., & Crabb, D. W. (2003) · Hepatology · doi:10.1053/jhep.2003.50095 · Cited by 346
Pathological Features of Fatty Liver Disease
Yeh, M. M., & Brunt, E. M. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.07.056 · Cited by 352
Systemic Levels of Lipid Peroxidation and Its Metabolic and Dietary Correlates in Patients with Nonalcoholic Steatohepatitis
Chalasani, N., Deeg, M. A., & Crabb, D. W. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.30159.x · Cited by 343
Hepatic steatosis in obese patients: clinical aspects and prognostic significance
Festi, D., Colecchia, A., Sacco, T., Bondi, M., Roda, E., & Marchesini, G. (2004) · Obesity Reviews · doi:10.1111/j.1467-789x.2004.00126.x · Cited by 308
Liver Enzymes, the Metabolic Syndrome, and Incident Diabetes
Nannipieri, M., Gonzales, C., Baldi, S., Posadas‐Sánchez, R., Williams, K., Haffner, S. M., D, M. P. S. M., & Ferrannini, E. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1757 · Cited by 309
Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity
García‐Monzón, C., Martín‐Pérez, E., Iacono, O. L., Fernández‐Bermejo, M., Majano, P. L., Apolinario, A., Larrañaga, E., & Moreno‐Otero, R. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80301-3 · Cited by 269
Association Between Elevated Liver Enzymes and C-Reactive Protein
Kerner, A., Avizohar, O., Sella, R., Bartha, P., Zinder, O., Markiewicz, W., Levy, Y., Brook, G. J., & Aronson, D. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000148324.63685.6a · Cited by 257
Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss.
Luyckx, F., Lefebvre, P. J., & Scheen, A. J. (2000) · PubMed · Cited by 244
High-fat emulsion-induced rat model of nonalcoholic steatohepatitis
Zou, Y., Li, J., Lü, C., Wang, J., Ge, J., Huang, Y., Zhang, L., & Wang, Y. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.03.021 · Cited by 246
III. Peroxisomal β-oxidation, PPARα, and steatohepatitis
Reddy, J. K. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.281.6.g1333 · Cited by 233
Altered expression of fatty acid–metabolizing enzymes in aromatase-deficient mice
Nemoto, Y., Toda, K., Ono, M., Fujikawa‐Adachi, K., Saibara, T., Onishi, S., Enzan, H., Okada, T., & Shizuta, Y. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9575 · Cited by 230
Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy†
Javor, E. D., Ghany, M. G., Cochran, E. K., Oral, E. A., DePaoli, A. M., Premkumar, A., Kleiner, D. E., & Gorden, P. (2005) · Hepatology · doi:10.1002/hep.20672 · Cited by 228
Gastrointestinal complications of diabetes mellitus
Krishnan, B. (2013) · World Journal of Diabetes · doi:10.4239/wjd.v4.i3.51 · Cited by 226
Resveratrol inhibits nonalcoholic fatty liver disease in rats
Bujanda, L., Hijona, E., Larzábal, M., Beraza, M., Aldazábal, P., García‐Urkía, N., Sarasqueta, C., Cosme, Á., Irastorza, B., González, A., et al. (2008) · BMC Gastroenterology · doi:10.1186/1471-230x-8-40 · Cited by 226
Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease
Sumida, Y., Nakashima, T., Yoh, T., Furutani, M., Hirohama, A., Kakisaka, Y., Nakajima, Y., Ishikawa, H., Mitsuyoshi, H., Okanoue, T., et al. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00331-8 · Cited by 216
Effect of Rosiglitazone on Insulin Sensitivity and Body Composition in Type 2 Diabetic Patients
Carey, D., Cowin, G., Galloway, G. J., Jones, N. P., Richards, J. C., Biswas, N., & Doddrell, D. M. (2002) · Obesity Research · doi:10.1038/oby.2002.137 · Cited by 210
Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia
Hyogo, H., Tazuma, S., Arihiro, K., Iwamoto, K., Nabeshima, Y., Inoue, M., Ishitobi, T., Nonaka, M., & Chayama, K. (2008) · Metabolism · doi:10.1016/j.metabol.2008.07.030 · Cited by 205
The epidemiology, pathogenesis and histopathology of fatty liver disease
Levene, A., & Goldin, R. D. (2012) · Histopathology · doi:10.1111/j.1365-2559.2011.04145.x · Cited by 195
Non‐alcoholic fatty liver syndrome: A hepatic consequence of common metabolic diseases
Angelico, F., Ben, M. D., Conti, R., Francioso, S., Feole, K., Maccioni, D., Antonini, T., & Alessandri, C. (2003) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2003.02958.x · Cited by 189
Uric acid and anti-TNF antibody improve mitochondrial dysfunction in ob/ob mice
García‐Ruíz, I., Rodríguez‐Juan, C., Díaz-Sanjuán, T., del Hoyo, P., Colina, F., Muñoz‐Yagüe, T., & Solis-Herruzo, J. A. (2006) · Hepatology · doi:10.1002/hep.21313 · Cited by 192
Elevated levels of serum advanced glycation end products in patients with non‐alcoholic steatohepatitis
Hyogo, H., Yamagishi, S., Iwamoto, K., Arihiro, K., Takeuchi, M., Sato, T., Ochi, H., Nonaka, M., Nabeshima, Y., Inoue, M., et al. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04943.x · Cited by 188
Concurrence of Histologic Features of Steatohepatitis with Other Forms of Chronic Liver Disease
Brunt, E. M., Ramrakhiani, S., Cordes, B. G., Neuschwander‐Tetri, B. A., Janney, C. G., Bacon, B. R., & Bisceglie, A. M. D. (2003) · Modern Pathology · doi:10.1097/01.mp.0000042420.21088.c7 · Cited by 182
Non‐alcoholic steatohepatitis (NASH): where are we now and where are we going?
Day, C. P. (2002) · Gut · doi:10.1136/gut.50.5.585 · Cited by 181
Self-citation
Dietary Fructans, but Not Cellulose, Decrease Triglyceride Accumulation in the Liver of Obese Zucker fa/fa Rats
Daubioul, C., Rousseau, N., Taper, H. S., Declerck, B., Delzenne, N. M., Demeure, R., & Gallez, B. (2002) · Journal of Nutrition · doi:10.1093/jn/132.5.967 · Cited by 178
Hepatocellular carcinoma arising in non‐alcoholic steatohepatitis
Zen, Y., Katayanagi, K., Tsuneyama, K., Harada, K., Araki, I., & Nakanuma, Y. (2001) · Pathology International · doi:10.1046/j.1440-1827.2001.01174.x · Cited by 174
Hepatic steatosis in Cushing's syndrome: a radiological assessment using computed tomography
Rockall, A., Sohaib, S., Evans, D., Kaltsas, G., Isidori, A. M., Monson, J., BESSER, G. M., Grossman, A. B., & Reznek, R. H. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490543 · Cited by 174
Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey
Shen, L. (2003) · World Journal of Gastroenterology · doi:10.3748/wjg.v9.i5.1106 · Cited by 171
Concurrent disorders in dogs with diabetes mellitus: 221 cases (1993–1998)
Hess, R. S., Saunders, H., Winkle, T. J. V., & Ward, C. R. (2000) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.2000.217.1166 · Cited by 167
Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients
Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD), Nakahara, T., Hyogo, H., Yoneda, M., Sumida, Y., Eguchi, Y., Fujii, H., Ono, M., Kawaguchi, T., Imajo, K., et al. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-013-0911-1 · Cited by 167
Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH
Kimura, Y., Hyogo, H., Yamagishi, S., Takeuchi, M., Ishitobi, T., Nabeshima, Y., Arihiro, K., & Chayama, K. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-010-0203-y · Cited by 160
Liver diseases and metabolic syndrome
Watanabe, S., Yaginuma, R., Ikejima, K., & Miyazaki, A. (2008) · Journal of Gastroenterology · doi:10.1007/s00535-008-2193-6 · Cited by 158
Liver steatosis in juvenile obesity: correlations with lipid profile, hepatic biochemical parameters and glycemic and insulinemic responses to an oral glucose tolerance test
Guzzaloni, G., Grugni, G., Minocci, A., Moro, D., & Morabito, F. C. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801224 · Cited by 157
Association between microsomal triglyceride transfer protein gene polymorphism and the biological features of liver steatosis in patients with Type II diabetes
Bernard, S., Touzet, S., Personne, I., Lapras, V., Bondon, P.-J., Berthezène, F., & Moulin, P. (2000) · Diabetologia · doi:10.1007/s001250051481 · Cited by 153
Regulation of fat metabolism in the liver: link to non-alcoholic hepatic steatosis and impact of physical exercise
Lavoie, J.-M., & Gauthier, M. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6600-y · Cited by 152
Obesity and liver disease
Scheen, A. J., & Luyckx, F. (2002) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.2002.0225 · Cited by 146
Leptin enhances TNF-α production via p38 and JNK MAPK in LPS-stimulated Kupffer cells
Shen, J., Sakaida, I., Uchida, K., Terai, S., & OKITA, K. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.04.004 · Cited by 163
Diseases and disorders associated with excess body weight.
Knight, J. A. (2011) · PubMed · Cited by 122
Expression of p53, Bax and Bcl-2 proteins in hepatocytes in non-alcoholic fatty liver disease
Panasiuk, A. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i38.6198 · Cited by 125
Pomegranate flower ameliorates fatty liver in an animal model of type 2 diabetes and obesity
Xu, K. Z., Zhu, C., Kim, M. S., Yamahara, J., & Li, Y. (2009) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.03.035 · Cited by 120
Effects of obstructive sleep apnea syndrome on serum aminotransferase levels in obese patients
Chin, K., Nakamura, T., Takahashi, K. P., Sumi, K., Ogawa, Y., Masuzaki, H., Muro, S., Hattori, N., Matsumoto, H., Niimi, A., et al. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01570-x · Cited by 121
Clinical trial: insulin‐sensitizing agents may reduce consequences of insulin resistance in individuals with non‐alcoholic steatohepatitis
Idılman, R., Mızrak, D., CORAPCIOGLU, D., Bektaş, M., Doğanay, B., Saykı, M., Çoban, Ş., Erden, E., Soykan, İ., Emral, R., et al. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03723.x · Cited by 119
Hepatic sexual dimorphism — implications for non-alcoholic fatty liver disease
Lefèbvre, P., & Staels, B. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00538-6 · Cited by 121
Salacia oblonga root improves postprandial hyperlipidemia and hepatic steatosis in Zucker diabetic fatty rats: Activation of PPAR-α
HSUNWEIHUANG, T., PENG, G., QIANLI, G., YAMAHARA, J., Roufogalis, B. D., & Li, G. Q. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.05.003 · Cited by 115
Autophagy Deficiency by Hepatic FIP200 Deletion Uncouples Steatosis From Liver Injury in NAFLD
Ma, D., Molusky, M. M., Song, J., Hu, C.-R., Fang, F., Rui, C., Mathew, A. V., Pennathur, S., Liu, F., Cheng, J., et al. (2013) · Molecular Endocrinology · doi:10.1210/me.2013-1153 · Cited by 113
Alcoholic and nonalcoholic steatohepatitis
Brunt, E. M. (2002) · Clinics in Liver Disease · doi:10.1016/s1089-3261(02)00002-8 · Cited by 113
The Epidemiology and Risk Factors of NASH
McCullough, A. J. (2004) · Wiley eBooks · doi:10.1002/9780470987438.ch3 · Cited by 110
Sympathetic Nervous System Catecholamines and Neuropeptide Y Neurotransmitters Are Upregulated in Human NAFLD and Modulate the Fibrogenic Function of Hepatic Stellate Cells
Sigala, B., McKee, C. M., Soeda, J., Pazienza, V., Morgan, M. L., Lin, C., Selden, C., Borght, S. V., Mazzoccoli, G., Roskams, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072928 · Cited by 110
Inflammatory Mediators of Hepatic Steatosis
Hijona, E., Hijona, L., Arenas, J. I., & Bujanda, L. (2010) · Mediators of Inflammation · doi:10.1155/2010/837419 · Cited by 105
Relation of elevated serum alanine aminotransferase activity with iron and antioxidant levels in the United States
Ruhl, C. E., & Everhart, J. E. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00395-0 · Cited by 107
Non‐alcoholic fatty liver disease
Alba, L. M., & Lindor, K. D. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01493.x · Cited by 105
Efficacy of rosuvastatin for the treatment of non‐alcoholic steatohepatitis with dyslipidemia: An open‐label, pilot study
Nakahara, T., Hyogo, H., Kimura, Y., Ishitobi, T., Arihiro, K., Aikata, H., Takahashi, S., & Chayama, K. (2012) · Hepatology Research · doi:10.1111/j.1872-034x.2012.01034.x · Cited by 103
Nonalcoholic steatohepatitis: risk factors for liver fibrosis
Shimada, M. (2002) · Hepatology Research · doi:10.1016/s1386-6346(02)00246-2 · Cited by 102
Models of Alcoholic Liver Disease in Rodents: A Critical Evaluation
Hall, P. D. L. Μ., Lieber, C. S., DeCarli, L. M., French, S. W., Lindros, K. O., Järveläinen, H. A., Bode, C., Parlesak, A., & Bode, J. C. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02405.x · Cited by 99
Multiple short bouts of exercise over 12-h period reduce glucose excursions more than an energy-matched single bout of exercise
Holmstrup, M., Fairchild, T., Keslacy, S., Weinstock, R., & Kanaley, J. (2014) · Metabolism · doi:10.1016/j.metabol.2013.12.006 · Cited by 98
NASH and atherosclerosis are two aspects of a shared disease: Central role for macrophages
Bieghs, V., Rensen, P. C. N., Hofker, M. H., & Shiri‐Sverdlov, R. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.08.041 · Cited by 96
Non‐invasive markers to predict the liver fibrosis in non‐alcoholic fatty liver disease
Lydatakis, H., Hager, I. P., Kostadelou, E., Mpousmpoulas, S., Pappas, S. I., & Diamantis, I. D. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01312.x · Cited by 96
Specific immunization strategies against oxidized low-density lipoprotein: A novel way to reduce nonalcoholic steatohepatitis in mice
Bieghs, V., van Gorp, P. J., Walenbergh, S. M. A., Gijbels, M. J., Verheyen, F., Buurman, W. A., Briles, D. E., Hofker, M. H., Binder, C. J., & Shiri‐Sverdlov, R. (2012) · Hepatology · doi:10.1002/hep.25660 · Cited by 98
Gender-related variations in iron metabolism and liver diseases
Harrison-Findik, D. D. (2010) · World Journal of Hepatology · doi:10.4254/wjh.v2.i8.302 · Cited by 105
Non-alcoholic steatohepatitis: a common cause of progressive chronic liver injury?
Evans, C. D., Oien, K. A., MacSween, R. N. M., & Mills, P. R. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.9.689 · Cited by 94
Immature Citrus sunki Peel Extract Exhibits Antiobesity Effects by .BETA.-Oxidation and Lipolysis in High-Fat Diet-Induced Obese Mice
Kang, S., Shin, H., Kim, H.-M., Hong, Y.-S., Yoon, S., Kang, S.-W., Kim, J., Kim, M.-H., Ko, H., & Kim, S. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.35.223 · Cited by 92
Steatohepatitis in obese individuals
Youssef, W. I., & McCullough, A. J. (2002) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2002.0334 · Cited by 92
From the origin of NASH to the future of metabolic fatty liver disease
Geier, A., Tiniakos, D., Denk, H., & Trauner, M. (2021) · Gut · doi:10.1136/gutjnl-2020-323202 · Cited by 80
Efficacy of pitavastatin for the treatment of non‐alcoholic steatohepatitis with dyslipidemia: An open‐label, pilot study
Hyogo, H., Ikegami, T., Tokushige, K., Hashimoto, E., Inui, K., Matsuzaki, Y., Tokumo, H., Hino, F., & Tazuma, S. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00849.x · Cited by 83
Correlation between Fatty Liver and Coronary Risk Factors: A Population Study of Elderly Men and Women in Nagasaki, Japan.
Akahoshi, M., AMASAKI, Y., Soda, M., Tominaga, T., Ichimaru, S., Nakashima, E., Seto, S., & Yano, K. (2001) · Hypertension Research · doi:10.1291/hypres.24.337 · Cited by 80
Spleen Enlargement in Patients with Nonalcoholic Fatty Liver
Tsushima, Y., & Endo, K. (2000) · Digestive Diseases and Sciences · doi:10.1023/a:1005446418589 · Cited by 77
Liver-Specific Peroxisome Proliferator–Activated Receptor α Target Gene Regulation by the Angiotensin Type 1 Receptor Blocker Telmisartan
Clemenz, M., Frost, N., Schupp, M., Caron, S., Foryst‐Ludwig, A., Böhm, C., Hartge, M., Gust, R., Staels, B., Unger, T., et al. (2008) · Diabetes · doi:10.2337/db07-0839 · Cited by 79
Effects of combined therapy with resveratrol, continuous and interval exercises on apoptosis, oxidative stress, and inflammatory biomarkers in the liver of old rats with non-alcoholic fatty liver disease
Hajighasem, A., Farzanegi, P., & Mazaheri, Z. (2018) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2018.1441872 · Cited by 75
Preventive effects of total flavonoids of Litsea coreana leve on hepatic steatosis in rats fed with high fat diet
Wang, J., Li, J., Zou, Y., Cheng, W., Lu, C., Zhang, L., Ge, J., Huang, C., Jin, Y. J., Lv, X., et al. (2008) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2008.09.029 · Cited by 74
Pathology of steatohepatitis
Brunt, E. M., & TINIAKOS, D. G. (2002) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2002.0326 · Cited by 73
Bariatric Surgery-Induced Weight Loss Reduces Hepatic Lipid Peroxidation Levels and Affects Hepatic Cytochrome P-450 Protein Content
Bell, L. N., Temm, C. J., Saxena, R., Vuppalanchi, R., Schauer, P. R., Rabinovitz, M., Krasinskas, A. M., Chalasani, N., & Mattar, S. G. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181dbb572 · Cited by 72
Super paramagnetic iron oxide MRI shows defective Kupffer cell uptake function in non-alcoholic fatty liver disease
Asanuma, T., Ono, M., Kubota, K., Hirose, A., Hayashi, Y., Saibara, T., Inanami, O., Ogawa, Y., Enzan, H., Onishi, S., et al. (2009) · Gut · doi:10.1136/gut.2009.176651 · Cited by 72
Petalonia binghamiae Extract and Its Constituent Fucoxanthin Ameliorate High-Fat Diet-Induced Obesity by Activating AMP-Activated Protein Kinase
Kang, S., Shin, H., Kim, H.-M., Yoon, S., Kang, S.-W., Kim, J., Ko, H., & Kim, S. (2012) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf2047652 · Cited by 71
Restriction of dietary calories, fat and iron improves non‐alcoholic fatty liver disease
Yamamoto, M., Iwasa, M., Iwata, K., Kaito, M., Sugimoto, R., Urawa, N., Mifuji, R., Konishi, M., Kobayashi, Y., & Adachi, Y. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04548.x · Cited by 68
Pediatric Nonalcoholic Fatty Liver Disease
Bozic, M. A., Subbarao, G. C., & Molleston, J. P. (2013) · Nutrition in Clinical Practice · doi:10.1177/0884533613489153 · Cited by 68
Nonalcoholic Fatty Liver Disease and Obesity
Saadeh, S. N. (2007) · Nutrition in Clinical Practice · doi:10.1177/011542650702200101 · Cited by 66
Portal inflammation is associated with advanced histological changes in alcoholic and non-alcoholic fatty liver disease
Rakha, E. A., Adamson, L. M., Bell, E., Neal, K. R., Ryder, S. D., Kaye, P., & Aithal, G. P. (2010) · Journal of Clinical Pathology · doi:10.1136/jcp.2010.079145 · Cited by 66
CYP2E1 overexpression alters hepatocyte death from menadione and fatty acids by activation of ERK1/2 signaling
Schattenberg, J. M., Wang, Y., Rigoli, R. M., Koop, D. R., & Czaja, M. J. (2004) · Hepatology · doi:10.1002/hep.20067 · Cited by 66
Effects of obstructive sleep apnea syndrome on hepatic steatosis and nonalcoholic steatohepatitis
Tatsumi, K., & Saibara, T. (2005) · Hepatology Research · doi:10.1016/j.hepres.2005.09.014 · Cited by 65
Free fatty acids – do they play a central role in type 2 diabetes?
Arner, P. (2001) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2001.00031.x · Cited by 67
Curcumin eliminates oxidized LDL roles in activating hepatic stellate cells by suppressing gene expression of lectin-like oxidized LDL receptor-1
Kang, Q., & Chen, A. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.93 · Cited by 66
Open‐labeled pilot study of cysteine‐rich whey protein isolate supplementation for nonalcoholic steatohepatitis patients
Chitapanarux, T., Tienboon, P., Pojchamarnwiputh, S., & Leelarungrayub, D. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05865.x · Cited by 64

Authors: James, *., & Day, C.
Affiliations: Newcastle University (GB)
ORCID: Day, Christopher
Venue: The Lancet
Publisher: Elsevier BV
Published: 1999-05
Volume: 353
Issue: 9165
Pages: 1634-1636
ISSN: 0099-5355 (ISSN-L)
0140-6736
DOI: 10.1016/s0140-6736(99)00163-4
OpenAlex: W2075783257
Cited by: 271
References: 15
Citations by year: 2026: 1 · 2024: 1 · 2022: 2 · 2021: 6 · 2020: 3 · 2019: 2 · 2018: 7 · 2017: 7 · 2016: 7 · 2015: 6 · 2014: 8 · 2013: 17 · 2012: 9
FWCI: 17.97
Type: journal article
Language: en
Open access: green
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The Lancet (publishedVersion)
PubMed (publishedVersion)
Newcastle University ePrints (Newcastle Univesity)
Topics: Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
Keywords: nonalcoholic steatohepatitis, liver dysfunction, alcohol consumption, prevalence, health screening
MeSH terms: Diabetes Mellitus, Type 2, Fatty Liver, Hepatitis, Humans, Liver, Obesity, Lipid Peroxidation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Non‐alcoholic steatohepatitis: another disease of affluence

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks